VivoSim Labs, INC.
VIVS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001497253
In the last 90 days, VivoSim Labs, INC. insiders filed 1 open-market purchase and 0 sales; 25 institutions reported holding it in 13F filings for Q2 2026, worth $109.7K in total; no superinvestor holds it.
Superinvestors holding VIVS, Q2 2026
No superinvestor reported holding VIVS in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of VIVS each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q1 2023
0 superinvestors holding at quarter end
- Sold out
- ARK Invest
Q4 2022
1 superinvestor holding at quarter end
- Reduced
- ARK Invest (−22.0%)
Q3 2022
1 superinvestor holding at quarter end
- Reduced
- ARK Invest (−5.7%)
Q2 2022
1 superinvestor holding at quarter end
- Reduced
- ARK Invest (−4.7%)
Q1 2022
1 superinvestor holding at quarter end
- Reduced
- ARK Invest (−7.3%)
Q4 2021
1 superinvestor holding at quarter end
- Reduced
- ARK Invest (−13.5%)
Q3 2021
1 superinvestor holding at quarter end
- Reduced
- ARK Invest (−10.8%)
Q2 2021
1 superinvestor holding at quarter end
- Reduced
- ARK Invest (−29.4%)